Retention of specific yolk IgY in the human oral cavity

BioDrugs

Volumn 16, Issue 6, 2002, Pages 433-437

  Carlander, David ^a   Kollberg, Hans ^a   Larsson, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN Y; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; YOLK PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; DENTAL CARIES; DRUG EFFECT; EGG YOLK; HUMAN; IMMUNOTHERAPY; MOUTH CAVITY; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALIVA ANALYSIS; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; CHICKENS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; EGG YOLK; HUMANS; IMMUNOGLOBULINS; MIDDLE AGED; MOUTH; MOUTHWASHES; PSEUDOMONAS AERUGINOSA; SALIVA; TIME FACTORS;

EID: 12244263455     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200216060-00004     Document Type: Article

References (22)

1. Carlander D, Kollberg H, Wejaker PE, et al. Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections. Immunol Res 2000; 21 (1): 1-6
2. Larsson A, Balow RM, Lindahl TL, et al. Chicken antibodies: Taking advantage of evolution: A review. Poult Sci 1993; 72 (10): 1807-12
3. Yokoyama H, Peralta RC, Umeda K, et al. Prevention of fatal salmonellosis in neonatal calves, using orally administered chicken egg yolk Salmonella-specific antibodies. Am J Vet Res 1998; 59 (4): 416-20
4. Ikemori Y, Ohta M, Umeda K, et al. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder. Vet Microbiol 1997; 58 (2-4): 105-11
5. Cama VA, Sterling CR. Hyperimmune hens as a novel source of anti-Cryptosporidium antibodies suitable for passive immune transfer. J Protozool 1991; 38 (6): 42S-3S
6. Hamada S, Horikoshi T, Minami T, et al. Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans. Infect Immun 1991; 59 (11): 4161-7
7. Otake S, Nishihara Y, Makimura M, et al. Protection of rats against dental caries by passive immunization with hen-egg-yolk antibody (IgY). J Dent Res 1991; 70 (3): 162-6
8. Carlander D, Kollberg H, Wejaker PE, et al. Prevention of chronic Pseudomonas aeruginosa colonisation by gargling with specific antibodies. In: Sim JS, editor. Egg Nutrition and Biotechnology. Wallingford, Oxon: CAB International, 1990: 371-4
9. Kollberg H, Larsson A, Carlander D. More than four years without any new pseudomonas infections at Uppsala cystic fibrosis centre [abstract]. Pediatr Pulmonol Suppl 1998; 17:313
10. Ratnaningsih E, Dharmsthiti S, Krishnapillai V, et al. A combined physical and genetic map of Pseudomonas aeruginosa PAO. J Gen Microbiol 1990; 136 (Pt 12): 2351-7
11. Lanyi B, Bergan T. Serological characterization of Pseudomonas aeruginosa. Methods Microbiol 1978; 10 (IV): 94-168
12. Akita EM, Nakai S. Immunoglobulins from egg yolk: Isolation and purification. J Food Sci 1992; 57 (32): 629-34
13. Carlander D, Sundstrom J, Berglund A, et al. Immunoglobulin Y (IgY): A new tool for the prophylaxis against Pseudomonas aeruginosa in cystic fibrosis patients [abstract]. Pediatr Pulmonol Suppl 1999; 19: 241
14. Pedersen SS, Jensen T, Hoiby N, et al. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr Scand 1987; 76 (6): 955-61
15. Levy SB. The challenge of antibiotic resistance. Sci Am 1998; 278 (3): 46-53
16. Nicolaou KC, Boddy CN. Behind enemy lines. Sci Am 2001; 284 (5): 54-61
17. Shale DJ, Elborn JS. Lung injury. In: Shale DJ, editor. Cystic Fibrosis. London: BMJ Publishing Group, 1996: 62-78
18. Bernhisel-Broadbent J, Yolken RH, Sampson HA. Allergenicity of orally administered immunoglobulin preparations in food-allergic children. Pediatrics 1991; 87(2): 208-14
19. Russo M, Nahori MA, Lefort J, et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol 2001; 24 (5): 518-26
20. Matsunaga Y, Wakatsuki Y, Tabata Y, et al. Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization. Vaccine 2000; 19(4-5): 579-88
21. The international egg commission [online]. Available from URL: http://www.internationalegg.com [Accessed 2002 Nov 1]
22. Hochberg MC, Tielsch J, Munoz B, et al. Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: The SEE project. Salisbury Eye Evaluation. J Rheumatol 1998; 25 (3): 486-91